Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beijing Vigoo Biological
Beijing, China
- Ownership
- Private
- Development stage
- Other
01
Overview
Constructing and operating a major national vaccine R&D and pilot manufacture center supporting development of vaccines for H1N1 influenza, hepatitis, and measles viruses
- Therapeutic areas
- Infectious Diseases
- Modalities
- Vaccine
- Industry
- Biotech
02
Partnerships
China National Biotec GroupBeijing Tiantan Biological Products CorpBeijing Biological Products Research InstituteChinese Disease Prevention and Control Center
Beyond the preview
Go deeper on Beijing Vigoo Biological.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Beijing Vigoo Biological.